Taiwan FDA registration 1595a4a43b1579ec04b87aabc74e0f30
Abbott second-generation creatinine assay set
TW: 亞培第二代肌酸酐檢驗試劑組
Taiwan·Risk Class 2·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Sep 30, 2022 – Sep 30, 2027ActiveRegistration details
- Analysis ID
- 1595a4a43b1579ec04b87aabc74e0f30
- Customs Code
- DHA05603585807
Company information
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used to quantify creatinine in human serum, plasma or urine on the Alinity c System.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1225 肌氨酸酐試驗系統(Creatininetestsystem)
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Sep 30, 2022
- Expiry Date
- Sep 30, 2027
About this record
Access comprehensive regulatory information for Abbott second-generation creatinine assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1595a4a43b1579ec04b87aabc74e0f30 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices